DK1418941T3 - Induktion af immunrespons mod felint immundefektvirus - Google Patents

Induktion af immunrespons mod felint immundefektvirus

Info

Publication number
DK1418941T3
DK1418941T3 DK02740841.8T DK02740841T DK1418941T3 DK 1418941 T3 DK1418941 T3 DK 1418941T3 DK 02740841 T DK02740841 T DK 02740841T DK 1418941 T3 DK1418941 T3 DK 1418941T3
Authority
DK
Denmark
Prior art keywords
gag
fiv
induction
vaccine
pro
Prior art date
Application number
DK02740841.8T
Other languages
English (en)
Inventor
Laurent Fischer
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of DK1418941T3 publication Critical patent/DK1418941T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02740841.8T 2001-06-01 2002-05-29 Induktion af immunrespons mod felint immundefektvirus DK1418941T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0107275A FR2825280B1 (fr) 2001-06-01 2001-06-01 Vaccination contre le virus de l'immunodeficience feline
PCT/FR2002/001809 WO2002096349A2 (fr) 2001-06-01 2002-05-29 Vaccination contre le virus de l'immunodeficience feline

Publications (1)

Publication Number Publication Date
DK1418941T3 true DK1418941T3 (da) 2010-11-01

Family

ID=8863923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02740841.8T DK1418941T3 (da) 2001-06-01 2002-05-29 Induktion af immunrespons mod felint immundefektvirus

Country Status (14)

Country Link
EP (1) EP1418941B9 (da)
JP (1) JP2004535406A (da)
AT (1) ATE473013T1 (da)
AU (1) AU2002314274B2 (da)
BR (1) BRPI0210229B1 (da)
CA (1) CA2448620C (da)
CZ (1) CZ305257B6 (da)
DE (1) DE60236943D1 (da)
DK (1) DK1418941T3 (da)
ES (1) ES2348226T3 (da)
FR (1) FR2825280B1 (da)
PL (1) PL210450B1 (da)
PT (1) PT1418941E (da)
WO (1) WO2002096349A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06005424A (es) 2003-11-13 2007-01-25 Univ Georgia Res Found Metodos para caracterizar virus de enfermedad bursal infecciosa.
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
CN106102781A (zh) 2013-08-29 2016-11-09 英联邦高等教育系统天普大学 用于hiv感染的rna指导的治疗的方法和组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2234995A (en) * 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US7255862B1 (en) * 1996-11-14 2007-08-14 Connaught Technology Corporation ALVAC/FIV constructs
CZ20014392A3 (cs) * 1999-06-10 2002-06-12 Merial Vakcína AND pro domácí a sportovní zvířata
EP1074625A3 (en) * 1999-06-14 2002-01-02 Pfizer Products Inc. DNA vaccine against feline immunodeficiency virus

Also Published As

Publication number Publication date
PT1418941E (pt) 2010-10-12
WO2002096349A2 (fr) 2002-12-05
WO2002096349A3 (fr) 2004-03-11
PL210450B1 (pl) 2012-01-31
JP2004535406A (ja) 2004-11-25
CZ305257B6 (cs) 2015-07-08
FR2825280B1 (fr) 2005-04-15
BR0210229A (pt) 2004-07-20
CZ20033229A3 (cs) 2004-03-17
CA2448620A1 (en) 2002-12-05
FR2825280A1 (fr) 2002-12-06
ATE473013T1 (de) 2010-07-15
CA2448620C (en) 2013-05-28
EP1418941A2 (fr) 2004-05-19
ES2348226T3 (es) 2010-12-01
EP1418941B1 (fr) 2010-07-07
AU2002314274B2 (en) 2008-03-20
EP1418941B9 (fr) 2010-10-20
DE60236943D1 (de) 2010-08-19
BRPI0210229B1 (pt) 2016-11-22
PL365742A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
CY1107818T1 (el) Hiv-1 tat, ή παραγωγα αυτου για προφυλακτικο και θεραπευτικο εμβολιασμο
DK0956360T3 (da) Poxvirusbaserede ekspressionsvektorer indeholdende heterologe inserts afledt af lentvirus
ZA200701176B (en) Vaccines against aids comprising CMV/R-nucleic acid constructs
ATE526411T1 (de) Avirulente, immunogene flavivirus-chimäre
WO2001091536A3 (en) Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
CY1107570T1 (el) Ανοσογονικα πολυπεπτιδια κωδικοποιουμενα απο μινιγονιδια mage και οι χρησεις τους
WO2005110492A3 (en) Method of using adenoviral vectors to induce an immune response
BR0206823A (pt) Gene quimérico, proteìna quimérica, vìrus recombinante, composição de vacina, uso de uma composição de vacina, combinação terapêutica ou preventiva, e, plasmìdeo
DK0652287T3 (da) Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom
ATE294857T1 (de) Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze
DK1418941T3 (da) Induktion af immunrespons mod felint immundefektvirus
FR2829498B1 (fr) Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
EP1439856A4 (en) RECOMBINANT TOLLWOOD VACCINES AND METHOD FOR THEIR PREPARATION AND USE
WO2005027844A3 (en) Dna vaccine compositions and methods of use
FI953371A (fi) TBE-virusinfektiota vastaan tähtäävään immunisointiin tarkoitetut parannetut rokotteet sekä menetelmä niiden valmistamiseksi
ATE335507T1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
MX2022007217A (es) Vacuna epitópica para virus de fiebre porcina africana.
DE69433057D1 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
RU2020118606A (ru) Вакцина против кошачьего калицивируса
DK284389A (da) Precursorantigener
CY1113749T1 (el) Συνθεσεις εμβολιων dna και μεθοδοι χρησης τους
CY1116971T1 (el) Ανοσογονες χιμαιρες δαγκειου ιου 2